Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Diseases (Basel, Switzerland)|June 2, 2021
Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid LeukemiaCarmen Fava, Simona Bernardi, Enrico Marco Gottardi, et al.Cell Biology International|March 1, 2025
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically EquivalentAlessia Cavalleri, Besjana Xhahysa, Silvia Mutti, et al.Mediterranean Journal of Hematology and Infectious Diseases|July 13, 2017
Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre ExperienceMichele Malagola, Bendetta Rambaldi, Giuseppe Ravizzola, et al.Plos One|February 24, 2017
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells)Simone Perucca, Andrea Di Palma, Pier Paolo Piccaluga, et al.Cells|September 23, 2022
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway InhibitorsSilvia Codenotti, Daniela Zizioli, Luca Mignani, et al.Journal of Tissue Engineering|May 21, 2019
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiationFederica Re, Luciana Sartore, Vladimira Moulisova, et al.Cancers|November 11, 2022
Timely Leukapheresis May Interfere with the "Fitness" of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL PatientsMirko Farina, Marco Chiarini, Camillo Almici, et al.Cancer Medicine|April 6, 2019
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuationSimona Bernardi, Michele Malagola, Camilla Zanaglio, et al.Mediterranean Journal of Hematology and Infectious Diseases|September 19, 2019
CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted PatientsMichele Malagola, Raffaella Greco, Stella Santarone, et al.Bone Marrow Transplantation|June 24, 2026
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remissionDaniele Avenoso, Vera Radici, Alessandro Leoni, et al.Pageof 7